申请人:TADESSE Dawit
公开号:US20160002203A1
公开(公告)日:2016-01-07
The present disclosure relates to Quinazolin-4(3H)-one-Type Piperidine Compounds, such as those of Formula (I) and the pharmaceutically acceptable salts and solvates thereof, wherein R
1
, R
2
, R
3
, Q, Y
1
, Z, A, B, E, and a are as defined herein; compositions comprising an effective amount of a Quinazolin-4(3H)-one-Type Piperidine Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Quinazolin-4(3H)-one-Type Piperidine Compound.
本公开涉及喹唑啉-4(3H)-酮型哌啶化合物,例如公式(I)中的化合物及其药学上可接受的盐和溶剂化物,其中R1、R2、R3、Q、Y1、Z、A、B、E和a的定义如本文所述;包含有效量喹唑啉-4(3H)-酮型哌啶化合物的组合物;以及通过向需要治疗或预防疾病,例如疼痛的动物施用有效量喹唑啉-4(3H)-酮型哌啶化合物的方法。